
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270304
DTSTAMP:20260802T222653Z
CREATED:20260802T222639Z
LAST-MODIFIED:20260802T222653Z
UID:10000854-1803772800-1804118399@oncodaily.com
SUMMARY:AACR Immuno-Oncology 2027
DESCRIPTION:AACR Immuno-Oncology 2027: Discovery and Innovation in Cancer Immunology—Revolutionizing Treatment Through Immunotherapy\, organized by the American Association for Cancer Research (AACR)\, will take place on 28 February–3 March 2027 at the JW Marriott Los Angeles L.A. Live in Los Angeles\, California. \nThe conference will bring together basic scientists\, translational researchers\, clinical investigators\, regulators\, industry professionals\, investors\, and international immuno-oncology leaders to explore advances in cancer immunology\, inflammation\, immunotherapy drugs\, immune modulators\, vaccines\, and cellular therapies. The programme will feature keynote lectures\, scientific symposia\, spotlight and educational sessions\, poster presentations\, exhibits\, and late-breaking clinical trial sessions highlighting novel agents\, treatment combinations\, and potentially practice-changing research.
URL:https://oncodaily.com/event/aacr-immuno-oncology-557996
LOCATION:JW Marriott Los Angeles L.A. Live\, 900 West Olympic Boulevard\, Los Angeles\, CA\, 90015\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/04/AACR-congress-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270301
DTEND;VALUE=DATE:20270304
DTSTAMP:20260802T225505Z
CREATED:20260802T225505Z
LAST-MODIFIED:20260802T225505Z
UID:10000855-1803859200-1804118399@oncodaily.com
SUMMARY:AACR Conference on Aneuploidy in Cancer
DESCRIPTION:The AACR Conference on Aneuploidy and Chromosomally Complex Cancers\, organized by the American Association for Cancer Research (AACR)\, will take place on 1–3 March 2027 at the JW Marriott Parq Vancouver in Vancouver\, British Columbia\, Canada. \nThe conference will focus on aneuploidy and chromosomal complexity in cancer and will be co-chaired by Samuel Aparicio of BC Cancer\, Sharon B. Cantor of UMass Chan Medical School\, and Karlene A. Cimprich of Stanford University. Additional programme\, registration\, and submission details have not yet been provided.
URL:https://oncodaily.com/event/aacr-conference-558000
LOCATION:JW Marriott Parq Vancouver\, 39 Smithe Street\, Vancouver\, British Columbia\, V6B 0R3\, Canada
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/04/AACR-congress-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270303
DTEND;VALUE=DATE:20270307
DTSTAMP:20261021T120831Z
CREATED:20261021T120831Z
LAST-MODIFIED:20261021T120831Z
UID:10001124-1804032000-1804377599@oncodaily.com
SUMMARY:ECHNO 2027 – 12th European Congress on Head and Neck Oncology
DESCRIPTION:The 12th European Congress on Head and Neck Oncology (ECHNO 2027) will take place from March 3–6\, 2027\, in Berlin\, Germany. \nOrganized under the auspices of the European Head and Neck Society (EHNS)\, with the German Interdisciplinary Head and Neck Group (IAG-KHT) representing the German host community\, ECHNO is one of the major European meetings dedicated to multidisciplinary head and neck oncology. \nThe 2027 congress will bring together specialists from across head and neck cancer care and research to discuss advances in surgery\, systemic therapy\, radiation oncology\, imaging\, pathology\, biomarkers\, liquid biopsy\, immunotherapy\, artificial intelligence\, personalized treatment\, and interdisciplinary care. \nThe scientific programme will feature keynote presentations\, round tables\, proffered paper sessions\, partner-society sessions\, industrial symposia\, poster presentations\, and a new series of 18 instructional courses focused on practical skills in head and neck cancer care.
URL:https://oncodaily.com/event/head-and-neck-oncology-613578
LOCATION:Maritim proArte Hotel Berlin\, Friedrichstraße 151\, Berlin\, Berlin\, 10117\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/Banner_Twitter_600x340.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270304
DTEND;VALUE=DATE:20270306
DTSTAMP:20261021T114115Z
CREATED:20261021T114115Z
LAST-MODIFIED:20261021T114115Z
UID:10001122-1804118400-1804291199@oncodaily.com
SUMMARY:Crossroads of Europe Oncology Summit 2027 (CEOS)
DESCRIPTION:The Crossroads of Europe Oncology Summit (CEOS) 2027 will take place on March 4–5\, 2027\, in Prague\, Czech Republic. \nThe new meeting is designed as a dedicated platform for the oncology community across Central\, Eastern\, and Western Europe\, with a particular focus on differences in access to innovation\, treatment\, research\, and resources across the region. \nCEOS 2027 aims to bring together oncology professionals\, experts\, policymakers\, and young professionals to exchange clinical experience\, share successful approaches\, and strengthen collaboration across European countries. The summit emphasizes reducing geographic disparities in cancer care and supporting young oncologists in developing their careers within their home countries. \nThe programme will cover major areas of contemporary oncology\, including prevention and survivorship\, breast\, prostate\, colorectal\, lung and gynecological cancers\, molecular diagnostics\, personalized medicine\, and access to research and care. Invited speakers include internationally recognized specialists such as Giuseppe Curigliano\, Nadia Harbeck\, Bohuslav Melichar\, Irit Ben-Aharon\, Silke Gillessen\, and Florian Lordick.
URL:https://oncodaily.com/event/europe-oncology-summit-613555
LOCATION:Grandium Hotel Prague\, Politických vězňů 913/12\, Prague\, Prague\, 110 00\, Czech Republic
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/CEOS-Prague-Oncology-Summit-Logo.webp
ORGANIZER;CN="Crossroads of Europe Oncology Summit (CEOS)":MAILTO:info@ceos27.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270304
DTEND;VALUE=DATE:20270307
DTSTAMP:20261008T195638Z
CREATED:20261008T195638Z
LAST-MODIFIED:20261008T195638Z
UID:10001097-1804118400-1804377599@oncodaily.com
SUMMARY:WMA GmbH – 13th Immunotherapy of Cancer Conference (ITOC13)
DESCRIPTION:The WMA GmbH – 13th Immunotherapy of Cancer Conference (ITOC13) will take place from March 4–6\, 2027\, in Munich\, Germany. \nITOC is a European meeting providing a global platform for translational research in immuno-oncology\, with a focus on early clinical translation and the challenges involved in advancing cancer immunotherapies. itoc-conference \nITOC13 is organized by WMA GmbH in scientific cooperation with the ITOC Association\, Tumor Centre in Munich (TZM)\, Wolfgang Wilmanns Stiftung (WWS)\, German Cancer Consortium (DKTK)\, Central European Cooperative Oncology Group (CECOG)\, Chinese American Hematologist and Oncologist Network (CAHON)\, and Comprehensive Cancer Center Munich (CCCM). \nThe conference aims to provide a platform for researchers and clinicians involved in cancer immunotherapy to exchange knowledge and discuss the latest findings shaping oncology drug development and delivery. itoc-conference \nThe preliminary scientific programme covers topics including tumor immunology and immunometabolism\, new therapeutic targets\, local immunotherapies\, bispecific antibodies\, multiple myeloma\, next-generation immune-activating concepts\, and emerging immunotherapy approaches\, alongside presentations from submitted abstracts and a dedicated young researcher session.
URL:https://oncodaily.com/event/13th-immunotherapy-of-cancer-conference-603995
LOCATION:Klinikum der Universität München\, Campus Großhadern\, Lecture Room 3\, Marchioninistraße 15\, Munich\, Bavaria\, 81377\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/iTOC13-Immunotherapy-Conference-Logo.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270304
DTEND;VALUE=DATE:20270308
DTSTAMP:20260923T115934Z
CREATED:20260923T115934Z
LAST-MODIFIED:20260923T115934Z
UID:10001060-1804118400-1804463999@oncodaily.com
SUMMARY:AACR Data Science and Artificial Intelligence in Oncology Conference 2027
DESCRIPTION:The AACR Data Science and Artificial Intelligence in Oncology Conference 2027 will take place from March 4–7\, 2027\, at the Hyatt Regency San Francisco Downtown SOMA in San Francisco\, California\, USA. \nOrganized by the American Association for Cancer Research (AACR)\, the conference will bring together researchers\, clinicians\, data scientists\, and technology experts to discuss the role of artificial intelligence and data science in advancing cancer research and care. \nThe meeting will explore the application of AI\, computational methods\, and large-scale data analysis in oncology\, including topics such as real-world data\, computational biology\, digital pathology\, medical imaging\, predictive modeling\, precision oncology\, and approaches to integrating data-driven tools into cancer research and clinical practice.
URL:https://oncodaily.com/event/artificial-intelligence-591788
LOCATION:Hyatt Regency San Francisco Downtown SOMA\, 50 Third Street\, San Francisco\, 94103
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/AACR-congress-1.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270308
DTEND;VALUE=DATE:20270311
DTSTAMP:20260822T124507Z
CREATED:20260822T124507Z
LAST-MODIFIED:20260822T124507Z
UID:10000939-1804464000-1804723199@oncodaily.com
SUMMARY:The ESMO Novel Cancer Therapies 2027
DESCRIPTION:The ESMO Novel Cancer Therapies 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on March 8–10\, 2027\, in Lugano\, Switzerland. \nThis new ESMO meeting is designed for multidisciplinary oncology professionals and will focus on how approved novel cancer therapies can be translated into everyday clinical practice\, with particular attention to treatment selection\, practical implementation\, toxicity prevention and management\, and optimizing patient outcomes. \nThe programme will combine expert presentations\, multidisciplinary discussions\, real-world clinical cases\, and peer-to-peer learning. Day 1 will feature a major focus on antibody-drug conjugates (ADCs)\, including their clinical use\, supportive care considerations\, management of ADC-related toxicities\, and practical issues around combinations and treatment sequencing. \nAccess the online programme.
URL:https://oncodaily.com/event/esmo-novel-cancer-therapies-572176
LOCATION:Lugano\, Lugano\, Ticino\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270310
DTEND;VALUE=DATE:20270313
DTSTAMP:20261008T211831Z
CREATED:20261008T211831Z
LAST-MODIFIED:20261008T211831Z
UID:10001101-1804636800-1804895999@oncodaily.com
SUMMARY:24th Annual ENETS Conference 2027
DESCRIPTION:The 24th Annual ENETS Conference 2027 will take place from March 10–12\, 2027\, in Milan\, Italy. \nOrganized by the European Neuroendocrine Tumor Society (ENETS)\, the conference is dedicated to the diagnosis and treatment of neuroendocrine tumor (NET) disease and will bring together specialists from across the neuroendocrine tumor community. \nThe meeting will be held as an onsite\, in-person event and will feature the 17th ENETS Postgraduate Course\, dedicated basic and translational science sessions\, and an intensive clinical science programme. \nThe programme includes topics spanning NEN diagnosis\, molecular classification\, imaging\, nuclear medicine\, treatment of advanced NETs\, systemic and locoregional therapies\, survivorship\, and management of treatment-related complications.
URL:https://oncodaily.com/event/enets-conference-604045
LOCATION:Allianz MiCo\, North Wing\, Gate 6\, Lodovico Scarampo 38\, Milan\, Lombardy\, 20148\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/Minimalist-Blue-ENETS-Wordmark.webp
ORGANIZER;CN="European Neuroendocrine Tumor Society (ENETS)":MAILTO:office@enets.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270313
DTEND;VALUE=DATE:20270314
DTSTAMP:20260829T191111Z
CREATED:20260829T191111Z
LAST-MODIFIED:20260829T191111Z
UID:10000971-1804896000-1804982399@oncodaily.com
SUMMARY:The 20th Annual New York GU Cancers Congress®
DESCRIPTION:The 20th Annual New York GU Cancers Congress®\, organized by Physicians’ Education Resource® (PER®)\, will take place on March 13\, 2027\, at the Conrad New York Downtown in New York City. \nNow in its 20th year\, the meeting will focus on advances in the management of genitourinary malignancies\, including prostate cancer\, renal cell carcinoma\, and bladder cancer. The programme is designed to help clinicians interpret rapidly evolving data on current and emerging therapies and apply treatment strategies according to patient and tumor characteristics. \nEducational formats will include expert presentations\, panel discussions\, and interactive tumor board-style case presentations\, with an emphasis on practical multidisciplinary management of GU cancers. The activity will offer AMA PRA Category 1 Credits™\, nursing contact hours\, and eligible ABIM MOC points.
URL:https://oncodaily.com/event/gu-cancers-congress-577246
LOCATION:Conrad New York Downtown\, 102 North End Avenue\, New York\, NY\, 10282\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/706mwvehjgmj-NYGU27_TICatalog750x3612x.webp
ORGANIZER;CN="Physicians%E2%80%99 Education Resource%C2%AE (PER%C2%AE)":MAILTO:info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270315
DTEND;VALUE=DATE:20270318
DTSTAMP:20260809T200333Z
CREATED:20260809T200333Z
LAST-MODIFIED:20260809T200333Z
UID:10000892-1805068800-1805327999@oncodaily.com
SUMMARY:The 3rd Edition of the International Cancer and Immuno-Oncology Conference - CIOC 2027
DESCRIPTION:The 3rd Edition of the International Cancer & Immuno-Oncology Conference (CIOC 2027)\, organized by Magnus Group LLC\, will take place on 15–17 March 2027 at Village Hotel Changi in Singapore\, with both in-person and virtual participation available. \nUnder the theme “Innovations in Cancer Research and Treatment for Better Patient Outcomes\,” the hybrid meeting will bring together oncologists\, researchers\, clinicians\, scientists\, healthcare professionals\, industry experts\, and students. \nThe scientific programme will cover cancer biology\, genetics and genomics\, precision medicine\, immunotherapy\, radiation oncology\, targeted therapies\, cancer prevention\, pediatric oncology\, supportive and palliative care\, survivorship\, clinical trials\, molecular diagnostics\, artificial intelligence\, and translational research. \nThe conference will feature keynote and plenary sessions\, oral and poster presentations\, workshops\, symposia\, panel discussions\, and networking opportunities. The first-round abstract deadline is 12 August 2026\, and early-bird registration closes 14 August 2026. Early-bird rates are $739 for in-person presenters\, $439 for virtual presenters\, $839 for in-person listeners\, and $539 for virtual listeners.
URL:https://oncodaily.com/event/cioc-2027-563146
LOCATION:Village Hotel Changi\, 1 Netheravon Road\, Singapore\, Singapore\, 508502\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/meta.webp
ORGANIZER;CN="Magnus Group LLC":MAILTO:info@magnusconference.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270316
DTEND;VALUE=DATE:20270319
DTSTAMP:20260806T142053Z
CREATED:20260806T142053Z
LAST-MODIFIED:20260806T142053Z
UID:10000875-1805155200-1805414399@oncodaily.com
SUMMARY:EACR Cancer Biology Conference 2027
DESCRIPTION:The EACR Conference: Cancer Biology – Virtual Systems & Beyond\, organized by the European Association for Cancer Research (EACR)\, will take place on 16–18 March 2027 at the Centro Congressi Giovanni XXIII in Bergamo\, Italy. \nThe meeting will bring together cancer researchers\, computational scientists\, clinicians\, and technology specialists to examine how computational models and virtual systems can support biological discovery and cancer care\, including their application in immunotherapy and the development of more reliable simulation and prediction approaches. \nThe programme will feature expert-led scientific sessions\, presentations from selected abstracts\, poster discussions\, and networking opportunities. The registration and payment deadline is 15 February 2027. Travel grants are available to eligible EACR student members and early-career members with fewer than four years of postdoctoral experience.
URL:https://oncodaily.com/event/cancer-biology-560869
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-6-2026-06_19_44-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270317
DTEND;VALUE=DATE:20270321
DTSTAMP:20260825T230738Z
CREATED:20260825T230738Z
LAST-MODIFIED:20260825T230738Z
UID:10000953-1805241600-1805587199@oncodaily.com
SUMMARY:The European Lung Cancer Congress 2027
DESCRIPTION:The European Lung Cancer Congress 2027 (ELCC 2027) will take place on March 17–20\, 2027\, in Munich\, Germany\, with both onsite and online participation. \nThe congress is jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) and brings together the multidisciplinary thoracic oncology community to advance science\, share education\, and improve clinical practice for patients with lung and other thoracic cancers. \nThe programme is designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians and pneumologists\, interventional radiologists\, pathologists\, and other professionals involved in thoracic cancer care\, with an emphasis on cross-specialty discussion\, emerging evidence\, and practical take-home insights that can inform everyday patient management.
URL:https://oncodaily.com/event/european-lung-cancer-congress-574706
LOCATION:ICM – International Congress Center Messe München\, Am Messesee 2\, Munich\, Bavaria\, 81829\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-03_05_49-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270317
DTEND;VALUE=DATE:20270321
DTSTAMP:20261021T112127Z
CREATED:20261021T112127Z
LAST-MODIFIED:20261021T112127Z
UID:10001121-1805241600-1805587199@oncodaily.com
SUMMARY:20th St.Gallen International Breast Cancer Conference 2027
DESCRIPTION:The 20th St.Gallen International Breast Cancer Conference (SGBCC 2027) will take place from March 17–20\, 2027\, at the Austria Center Vienna in Vienna\, Austria. \nThe anniversary edition will focus on “Primary Therapy of Patients with Early Breast Cancer: Evidence\, Controversies\, Consensus” and will bring together international experts to discuss the latest evidence shaping the treatment of early breast cancer. \nSGBCC is particularly notable for its St.Gallen International Breast Cancer Consensus Session\, where an international panel of breast cancer specialists discusses challenging issues in early breast cancer and develops evidence-based recommendations. The resulting St.Gallen Breast Cancer Consensus Guidelines are subsequently published internationally. \nThe 2027 scientific programme will cover relevant facets of early breast cancer care\, alongside state-of-the-art lectures and debates on controversial and emerging treatment questions.
URL:https://oncodaily.com/event/breast-cancer-conference-613545
LOCATION:Austria Center Vienna\, Bruno-Kreisky-Platz 1\, Vienna\, Vienna\, 1220\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/SGBCC27_SavetheDate-1.webp
ORGANIZER;CN="Foundation St.Gallen Oncology Conferences (SONK)":MAILTO:info@sonk.ch
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20270317T080000
DTEND;TZID=America/Halifax:20270320T170000
DTSTAMP:20260923T120748Z
CREATED:20260923T120748Z
LAST-MODIFIED:20260923T120748Z
UID:10001061-1805270400-1805562000@oncodaily.com
SUMMARY:20th St. Gallen International Breast Cancer Conference 2027
DESCRIPTION:The 20th St. Gallen International Breast Cancer Conference 2027 will take place from March 17–20\, 2027\, in Vienna\, Austria. \nOrganized by the St. Gallen Oncology Conferences\, the meeting will bring together international experts in breast oncology to discuss current evidence\, emerging research\, and treatment strategies for patients with early breast cancer. \nThe conference will focus on the latest developments in early breast cancer management\, including multidisciplinary treatment decisions\, molecular subtypes\, systemic therapies\, surgery\, radiation therapy\, biomarkers\, and personalized approaches to optimize patient outcomes. The meeting will also continue the St. Gallen tradition of expert discussions and consensus development on controversial topics in breast cancer care. \n 
URL:https://oncodaily.com/event/breast-cancer-591832
LOCATION:Vienna\, Vienna\, Vienna\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-23-2026-04_06_46-PM.webp
ORGANIZER;CN="St. Gallen Oncology Conferences":MAILTO:info@sonk.ch
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270319
DTEND;VALUE=DATE:20270323
DTSTAMP:20260810T141421Z
CREATED:20260810T141421Z
LAST-MODIFIED:20260810T141421Z
UID:10000898-1805414400-1805759999@oncodaily.com
SUMMARY:The 42nd Annual EAU Congress
DESCRIPTION:The 42nd Annual EAU Congress (EAU27)\, organized by the European Association of Urology (EAU)\, will take place on 19–22 March 2027 in Amsterdam\, the Netherlands. \nExpected to attract more than 10\,000 healthcare professionals\, the four-day congress will provide a comprehensive update on the latest innovations and scientific advances in urology. The programme will feature interactive discussions\, live surgery\, state-of-the-art lectures\, educational courses\, and hands-on training delivered through the European School of Urology. \nAttendees will also be able to explore new technologies and emerging innovations at the EAU27 Exhibition. Abstract submission is currently open\, alongside nominations for the EAU’s scientific and professional awards. EAU members receive a significant discount on congress registration and early access to accommodation booking in Amsterdam.
URL:https://oncodaily.com/event/42nd-annual-eau-congress-563477
LOCATION:RAI Amsterdam\, Europaplein 24\, Amsterdam\, North Holland\, 1078 GZ\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/EAU27-Social-media-image-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270319
DTEND;VALUE=DATE:20270321
DTSTAMP:20260810T145322Z
CREATED:20260810T145322Z
LAST-MODIFIED:20260810T145322Z
UID:10000899-1805414400-1805587199@oncodaily.com
SUMMARY:The Highlights of ASH 2027
DESCRIPTION:The Highlights of ASH in the Mediterranean\, Middle East\, and North Africa 2027\, organized by the American Society of Hematology (ASH)\, will take place on 19-20 March 2027 in Athens\, Greece. \nThis two-day\, in-person hematology meeting will bring together clinicians\, researchers\, trainees\, allied health professionals\, and other specialists to review and discuss the most influential and novel research presented at the latest ASH Annual Meeting. \nThe programme will cover advances across malignant and classical hematology\, with opportunities for real-time discussion with leading experts\, exploration of regional standards of care and emerging technologies\, and professional networking and mentorship. The programme will be presented in English\, and registration is scheduled to open in fall 2026. \nASH has not yet published the exact March 2027 dates\, venue\, detailed scientific programme\, or registration fees for the Athens meeting.
URL:https://oncodaily.com/event/ash-563552
LOCATION:Athens\, Athens\, Attica\, Greece
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-10-2026-06_29_42-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270319
DTEND;VALUE=DATE:20270323
DTSTAMP:20260810T152637Z
CREATED:20260810T152637Z
LAST-MODIFIED:20260810T152637Z
UID:10000900-1805414400-1805759999@oncodaily.com
SUMMARY:SGO 2027 Annual Meeting on Gynecologic Cancer
DESCRIPTION:The SGO 2027 Annual Meeting on Gynecologic Cancer\, organized by the Society of Gynecologic Oncology (SGO)\, will take place on 19–22 March 2027 in Phoenix\, Arizona. \nUnder the theme “Defining the Next Era\,” the meeting will bring together thousands of physicians\, researchers\, advanced practice providers\, trainees\, and industry partners to explore the latest advances in gynecologic oncology. \nThe scientific and educational programme will feature plenary and scientific sessions\, oral and poster abstract presentations\, masterclasses\, focused educational programming\, networking and mentorship opportunities\, and industry exhibits and innovations. \nThe meeting will highlight groundbreaking research\, emerging treatment strategies\, multidisciplinary education\, and practical insights aimed at improving outcomes for patients with gynecologic cancers. Abstract\, trials-in-progress\, surgical film\, and late-breaking abstract shell submissions are currently open.
URL:https://oncodaily.com/event/sgo-2027-563584
LOCATION:Phoenix\, Phoenix\, AZ\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-10-2026-07_16_43-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270322
DTEND;VALUE=DATE:20270324
DTSTAMP:20261003T210609Z
CREATED:20261003T210609Z
LAST-MODIFIED:20261003T210609Z
UID:10001087-1805673600-1805846399@oncodaily.com
SUMMARY:ESSO – Surgical Anatomy Course on Pancreatic Cancer
DESCRIPTION:The ESSO – Surgical Anatomy Course on Pancreatic Cancer will take place on March 22–23\, 2027\, at the Institute of Anatomy\, University Medical Center Hamburg-Eppendorf (UKE)\, in Hamburg\, Germany. \nOrganized by the European Society of Surgical Oncology (ESSO)\, this Level 1 hands-on course will combine surgical anatomy\, operative techniques\, and an update on current treatment concepts for pancreatic cancer within an evidence-based and multidisciplinary framework. \nThe course will provide participants with practical training in the surgical anatomy and operative management of pancreatic cancer\, including hands-on work with anatomical specimens and human cadavers. The programme will also include 3D model workshops\, a pre-course anatomy e-learning module\, plenary lectures\, and multidisciplinary team case discussions. \nMain topics will include complication management\, cystic lesions of the pancreas\, borderline resectable pancreatic ductal adenocarcinoma (PDAC)\, locally advanced pancreatic cancer (LAPC)\, and pancreatic neuroendocrine tumors.
URL:https://oncodaily.com/event/surgical-anatomy-course-600215
LOCATION:Institute of Anatomy\, University Medical Center Hamburg-Eppendorf\, Martinistraße 52\, Building N61\, Hamburg\, Hamburg\, 20246\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/esso-webinar-fallback-1024x724-1-1.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270323
DTEND;VALUE=DATE:20270325
DTSTAMP:20261008T201229Z
CREATED:20261008T201229Z
LAST-MODIFIED:20261008T201229Z
UID:10001099-1805760000-1805932799@oncodaily.com
SUMMARY:EORTC Summit on Clinical Cancer Research
DESCRIPTION:The EORTC Summit on Clinical Cancer Research 2027 will take place on March 23–24\, 2027\, at The SQUARE Brussels Meeting Centre in Brussels\, Belgium. \nOrganized by the European Organisation for Research and Treatment of Cancer (EORTC)\, the two-day Summit will bring together stakeholders across clinical cancer research to explore innovative methodologies\, patient-centric approaches\, quality of life\, artificial intelligence\, and global policy and regulatory trends. \nThe Summit will provide a forum for researchers\, clinicians\, patient advocates\, industry leaders\, regulators\, healthcare technology assessment bodies\, contract research organizations\, and funders to discuss how clinical cancer research can evolve and strengthen collaboration across the field.
URL:https://oncodaily.com/event/eortc-summit-604005
LOCATION:The SQUARE Brussels Meeting Centre\, Mont des Arts\, 1000 Bruxelles\, Brussels\, Brussels-Capital Region\, 1000\, Belgium
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/EORTC-Summit-2027-Brussels-Skyline.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270402
DTEND;VALUE=DATE:20270408
DTSTAMP:20260809T202401Z
CREATED:20260809T202401Z
LAST-MODIFIED:20260809T202401Z
UID:10000893-1806624000-1807142399@oncodaily.com
SUMMARY:The AACR Annual Meeting 2027
DESCRIPTION:The AACR Annual Meeting 2027\, organized by the American Association for Cancer Research (AACR)\, will take place on 2–7 April 2027 at the Orange County Convention Center in Orlando\, Florida. \nUnder the theme “Delivering Discovery Science: The Bridge to Breakthrough Therapeutics\,” the meeting will bring together scientists\, clinicians\, healthcare professionals\, survivors\, patients\, and advocates from around the world to present and discuss advances across the cancer research continuum. \nThe scientific programme will span population science and cancer prevention\, cancer biology\, translational and clinical research\, survivorship\, and advocacy\, alongside abstract presentations and opportunities for scientific exchange and collaboration. \nThe 2027 Program Committee is chaired by Sheila A. Stewart and Kurt Schalper. Regular abstract submission is expected to open in late September 2026\, with a deadline of 10 November 2026; the early registration deadline is 7 December 2026\, and late-breaking and clinical trial abstracts are due 6 January 2027.
URL:https://oncodaily.com/event/aacr-annual-meeting-563154
LOCATION:Orange County Convention Center\, 9800 International Drive\, Orlando\, FL\, 32819\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/88786c87561746fdaf9e137bbef4dec9.webp
ORGANIZER;CN="American Association for Cancer Research (AACR)":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270406
DTEND;VALUE=DATE:20270408
DTSTAMP:20260817T165522Z
CREATED:20260817T165522Z
LAST-MODIFIED:20260817T165522Z
UID:10000927-1806969600-1807142399@oncodaily.com
SUMMARY:The 2027 Community Oncology Conference
DESCRIPTION:The 2027 Community Oncology Conference\, organized by the Community Oncology Alliance (COA)\, will take place on April 6–7\, 2027 in Lake Buena Vista\, Florida. \nThe annual conference brings together professionals from across community oncology to discuss issues affecting cancer care\, practice operations\, policy\, innovation\, and the future of community-based oncology. The meeting will be held at the Walt Disney World Dolphin Hotel.
URL:https://oncodaily.com/event/community-oncology-conference-568525
LOCATION:Walt Disney World Dolphin Hotel\, 1500 Epcot Resorts Boulevard\, Lake Buena Vista\, FL\, 32830\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-17-2026-08_53_56-PM.webp
ORGANIZER;CN="Community Oncology Alliance (COA)":MAILTO:info@coacancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270411
DTEND;VALUE=DATE:20270414
DTSTAMP:20261008T212719Z
CREATED:20261008T212719Z
LAST-MODIFIED:20261008T212719Z
UID:10001102-1807401600-1807660799@oncodaily.com
SUMMARY:American Society of Preventive Oncology (ASPO) – 51st Annual Meeting
DESCRIPTION:The American Society of Preventive Oncology (ASPO) 51st Annual Meeting will take place from April 11–13\, 2027\, at the Emory Conference Center in Atlanta\, Georgia\, USA. \nThe 2027 meeting theme is “Susceptibility to Survivorship: Multidisciplinary Approaches to Prevention and Control for Childhood\, AYA\, and Early-Onset Cancers.” \nThe meeting will bring together researchers\, trainees\, and community and patient advocates working across cancer prevention and control. The scientific programme will include sessions on cancer and survivorship across the life course\, precision oncology access\, caregiver roles\, fertility and family planning\, financial considerations\, healthcare transitions\, cancer risk biology\, and new prevention and surveillance interventions.
URL:https://oncodaily.com/event/preventive-oncology-604053
LOCATION:Emory Conference Center\, 1615 Clifton Road NE\, Atlanta\, GA\, 30329\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/image-asset.webp
ORGANIZER;CN="American Society of Preventive Oncology":MAILTO:nationaloffice@aspo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270414
DTEND;VALUE=DATE:20270417
DTSTAMP:20261021T122059Z
CREATED:20261021T122059Z
LAST-MODIFIED:20261021T122059Z
UID:10001125-1807660800-1807919999@oncodaily.com
SUMMARY:19th International Congress on Myelodysplastic Syndromes (MDS 2027)
DESCRIPTION:The 19th International Congress on Myelodysplastic Syndromes (MDS 2027) will take place from April 14–16\, 2027\, in Leipzig\, Germany. \nThe congress will bring together the global MDS community\, including clinicians\, researchers\, healthcare professionals\, young investigators\, and industry representatives\, to discuss advances in the understanding\, diagnosis\, treatment\, and care of patients with myelodysplastic syndromes. \nThe three-day meeting will provide a platform for cutting-edge research\, expert-led discussions\, scientific symposia\, educational sessions\, workshops\, and abstract presentations. The programme is designed to connect basic\, translational\, and clinical research and to encourage collaboration across the international MDS community. \nMDS 2027 will address the biology and pathogenesis of MDS\, advances in diagnosis and molecular characterization\, prognostic and predictive factors\, emerging treatments\, transplantation\, supportive care\, and the growing role of artificial intelligence in MDS. \nSpecific disease entities including CHIP\, CCUS\, childhood MDS\, hereditary MDS\, MDS with SF3B1/ring sideroblasts\, MDS/MPN overlap syndromes\, del(5q) MDS\, treatment-related MDS\, and VEXAS will also be covered.
URL:https://oncodaily.com/event/myelodysplastic-syndromes-613587
LOCATION:KONGRESSHALLE am Zoo Leipzig\, Pfaffendorfer Str. 31\, Leipzig\, Saxony\, 04105\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/MDS-2027-16x9-1.webp
ORGANIZER;CN="Myelodysplastic Syndromes Foundation (MDSF)":MAILTO:support@mds-foundation.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270414
DTEND;VALUE=DATE:20270418
DTSTAMP:20261021T115642Z
CREATED:20261021T115642Z
LAST-MODIFIED:20261021T115642Z
UID:10001123-1807660800-1808006399@oncodaily.com
SUMMARY:17th International Gastric Cancer Congress (IGCC 2027)
DESCRIPTION:The 17th International Gastric Cancer Congress (IGCC 2027) will take place from April 14–17\, 2027\, in Santiago\, Chile\, under the theme “Gastric Cancer in the Real World.” \nOrganized by the International Gastric Cancer Association (IGCA)\, the congress will bring together surgeons\, oncologists\, pathologists\, gastroenterologists\, radiologists\, basic scientists\, nurses\, epidemiologists\, public-health specialists\, patient advocates\, and other professionals involved in gastric cancer care and research. \nThe meeting will focus on translating advances in gastric cancer research into practical approaches that can be applied across different healthcare settings. The scientific programme will address the full spectrum of gastric cancer\, from epidemiology\, prevention\, early detection\, and screening to surgery\, systemic therapy\, immunotherapy\, biomarkers\, palliative care\, and emerging technologies. \nIGCC 2027 will also provide opportunities for international collaboration and multidisciplinary discussion\, with plenary sessions\, scientific presentations\, workshops\, poster viewing\, and sessions dedicated to current clinical trials and novel approaches in gastric cancer.
URL:https://oncodaily.com/event/gastric-cancer-congress-613567
LOCATION:Metropolitan Santiago\, Costanera Sur S.J.E. de Balaguer 5600\, Vitacura\, Santiago\, Santiago Metropolitan Region\, 7640803\, Chile
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IGCC-2027-Santiago-Registration-Opens.webp
ORGANIZER;CN="International Gastric Cancer Association (IGCA)":MAILTO:igcc2027@ccmgroup.com.br
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270414
DTEND;VALUE=DATE:20270419
DTSTAMP:20261020T194456Z
CREATED:20261020T194456Z
LAST-MODIFIED:20261020T194456Z
UID:10001120-1807660800-1808092799@oncodaily.com
SUMMARY:52nd Annual ONS Congress 2027
DESCRIPTION:The 52nd Annual ONS Congress will take place from April 14–18\, 2027\, at the Walter E. Washington Convention Center in Washington\, DC\, USA. \nOrganized by the Oncology Nursing Society (ONS)\, the congress will bring together oncology nurses and other healthcare professionals for education\, professional development\, research exchange\, and discussion of advances in cancer care. \nThe 2027 congress will feature education across different stages of oncology nursing practice\, with sessions focused on symptom management\, cancer care delivery\, evidence-based practice\, research\, access\, quality and value in cancer care\, and professional development. The programme will include expert-led sessions\, oral abstract presentations\, poster presentations\, and industry-supported events. Attendees can also earn more than 20 NCPD contact hours. \nThe congress provides an opportunity for oncology professionals to share research and quality-improvement work while connecting with colleagues from across the cancer-care community. Accepted abstracts will be published in the Oncology Nursing Forum in spring 2027.
URL:https://oncodaily.com/event/52nd-annual-ons-congress-613117
LOCATION:Walter E. Washington Convention Center\, 801 Allen Y. Lew Place NW\, Washington\, DC\, 20001\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/ONS-Tapestry-Conference-Banner.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270415
DTEND;VALUE=DATE:20270416
DTSTAMP:20261020T100818Z
CREATED:20261020T100818Z
LAST-MODIFIED:20261020T100818Z
UID:10001119-1807747200-1807833599@oncodaily.com
SUMMARY:BE-PRECISE 2027: Belgian Precision and Personalised Oncology Meeting
DESCRIPTION:The 3rd Edition of BE-PRECISE – Belgian Precision and Personalised Oncology Meeting will take place on April 15\, 2027\, in Antwerp\, Belgium. \nThe meeting is organized by seven Belgian universities — UCLouvain\, UAntwerpen\, ULB\, ULiège\, KU Leuven\, UGent\, and VUB — and aims to strengthen collaboration and cross-talk between clinicians and researchers in precision oncology. \nUnder the theme “The precision of science will meet the compassion of care\,” BE-PRECISE 2027 will provide a platform for discussing the latest developments in precision and personalised oncology\, bringing together translational and clinical research. The meeting is designed to connect scientific advances with their application in patient care and to encourage collaboration across Belgian oncology research institutions. \nThe programme will feature invited and keynote speakers from several Belgian universities and international institutions. Confirmed topics and speakers include cancer biology\, microbiome and diet\, emerging technologies\, cell therapy\, and precision oncology\, alongside opportunities for researchers to present selected abstracts and ideas. \n 
URL:https://oncodaily.com/event/be-precise-2027-612693
LOCATION:Vestar\, Lamorinièrestraat 53\, Antwerp\, Antwerp\, 2018\, Belgium
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/BE-PRECISE-Conference-Logo-Banner.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270415
DTEND;VALUE=DATE:20270418
DTSTAMP:20261019T140221Z
CREATED:20261019T140221Z
LAST-MODIFIED:20261019T140221Z
UID:10001116-1807747200-1808006399@oncodaily.com
SUMMARY:23rd EADO Congress 2027
DESCRIPTION:The 23rd EADO Congress will take place from April 15–17\, 2027\, at the Hofburg Palace in Vienna\, Austria. \nHeld under the auspices of the European Association of Dermato-Oncology (EADO)\, the congress is a leading international meeting dedicated to dermato-oncology\, bringing together experts to discuss the latest advances in melanoma\, keratinocyte carcinomas\, and rare skin cancers. \nThe 2027 programme will feature keynote lectures\, state-of-the-art symposia\, free communications\, and sessions addressing emerging areas including cellular therapies\, real-world data\, new diagnostic technologies\, and artificial intelligence-supported clinical practice. More than 1\,300 participants and international experts are expected to attend. \nThe congress also offers researchers\, clinicians\, and trainees an opportunity to present their work through oral and poster presentations. Abstracts can address clinical\, translational\, or experimental research in melanoma and non-melanoma skin cancer\, with accepted abstracts published in the digital Book of Abstracts and the European Cancer Journal. \n 
URL:https://oncodaily.com/event/23rd-eado-congress-612037
LOCATION:Hofburg Vienna\, Heldenplatz\, Vienna\, Vienna\, 1010\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/EADO-Congress-2027-Save-the-Date.webp
ORGANIZER;CN="European Association of Dermato-Oncology":MAILTO:info@eado.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270420
DTEND;VALUE=DATE:20270423
DTSTAMP:20260929T121554Z
CREATED:20260929T121554Z
LAST-MODIFIED:20260929T121554Z
UID:10001074-1808179200-1808438399@oncodaily.com
SUMMARY:EACR – Overcoming Therapy Resistance: Outsmarting Intratumour Heterogeneity and Plasticity
DESCRIPTION:The EACR – Overcoming Therapy Resistance: Outsmarting Intratumour Heterogeneity and Plasticity conference will take place from April 20–22\, 2027\, in Lyon\, France.  \nOrganized by the European Association for Cancer Research (EACR)\, the conference will bring together international researchers\, clinicians\, and allied health professionals to explore the biological mechanisms driving cancer therapy resistance and strategies to overcome tumour adaptation. \nThe meeting will focus on intratumour heterogeneity (ITH)\, cellular plasticity\, and tumour evolution as key drivers of treatment resistance. The programme will explore how tumours adapt to different therapeutic approaches\, including targeted therapies\, immunotherapies\, and combination treatments\, and how the tumour immune microenvironment influences treatment response. \nSessions will address approaches to understanding and overcoming tumour complexity\, including spatial and temporal tumour evolution\, resistant cancer cell states such as persister cells and dormant cells\, tumour microenvironment rewiring\, adaptive therapies\, combination strategies\, and treatment timing and sequencing. \n 
URL:https://oncodaily.com/event/intratumour-heterogeneity-596781
LOCATION:Lyon\, Lyon\, Auvergne-Rhône-Alpes\, France
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-29-2026-04_15_04-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270501
DTEND;VALUE=DATE:20270506
DTSTAMP:20261010T231024Z
CREATED:20261010T231024Z
LAST-MODIFIED:20261010T231024Z
UID:10001103-1809129600-1809561599@oncodaily.com
SUMMARY:CIRSE – European Conference on Interventional Oncology (ECIO) 2027
DESCRIPTION:The CIRSE – European Conference on Interventional Oncology (ECIO) 2027 will take place from May 1–5\, 2027\, at the Palau de Congressos de Palma in Palma de Mallorca\, Spain.  \nHosted by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)\, ECIO is a major multidisciplinary meeting dedicated to interventional oncology and minimally invasive cancer care. ECIO \nECIO 2027 will bring together specialists from across disciplines to explore how interventional oncology is becoming increasingly integrated into multidisciplinary cancer care. The programme will combine scientific and educational sessions with practical learning\, tumour boards\, video-based teaching\, and hands-on opportunities.
URL:https://oncodaily.com/event/cirse-605624
LOCATION:Palau de Congressos de Palma\, Carrer de Felicià Fuster\, 2\, Palma de Mallorca\, Balearic Islands\, 07006\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/ECIO2027-Conference-Banner.webp
END:VEVENT
END:VCALENDAR